Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Proteon Therapeutics reports results from study of recombinant human elastase

Jan. 7, 2013

TheraVida reports topline Tolenix data in overactive bladder and urinary incontinence

Jan. 4, 2013

Relypsa reaches agreement with FDA for phase III trial of patiromer

Jan. 3, 2013

FDA accepts supplemental BLA filing for Xiaflex

Dec. 31, 2012

FDA approves La Jolla Pharmaceutical's IND for CKD drug

Dec. 7, 2012

Novel murine model of proteinuria developed at Washington University

Dec. 3, 2012

Enrollment complete in pivotal U.S. phase III trial of NX-1207

Nov. 30, 2012

Novel mouse model of NSF developed at Thomas Jefferson University

Nov. 30, 2012

Everolimus approved in new TSC indications in Japan

Nov. 22, 2012

Nymox to commence study evaluating repeat injections of NX-1207

Nov. 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.